Real-world effectiveness and safety of rituximab in the treatment of rheumatoid arthritis: A single-center experience in Taiwan.
Kai-Chun WangHsien-Tzung LiaoWei-Sheng ChenChien-Chih LaiChung-Tei ChouMing-Han ChenChang-Youh TsaiPublished in: International journal of rheumatic diseases (2019)
RTX was effective and safe in real-life management of RA patients with high disease activity. Patients taking concomitant methotrexate and with lower baseline DAS28-ESR were more likely to benefit from RTX.
Keyphrases
- disease activity
- rheumatoid arthritis
- systemic lupus erythematosus
- rheumatoid arthritis patients
- ankylosing spondylitis
- end stage renal disease
- juvenile idiopathic arthritis
- ejection fraction
- chronic kidney disease
- newly diagnosed
- prognostic factors
- high dose
- interstitial lung disease
- diffuse large b cell lymphoma
- low dose
- estrogen receptor